top of page


August 2022
TechScout Venture Fund

We are happy to share that we have been awarded €50.000,- from the Delft Enterprises TechScout Venture Fund. 

This will help us to progress our work on developing the mixed-culture fermentation process for the production of heparin-like compounds. In particular, this funding will support one of our current projects by allowing us to validate our low-anticoagulant heparin-like compound’s antiseptic and  anti-inflammatory potential.

Check out the post on our LinkedIn and reach out to us if you have any questions!

bottom of page